JN.1 variant symptoms and risks: Everything you should know

JN.1, a BA.2.86 sublineage with enhanced spike protein mutations, exhibits high transmissibility but limited pathogenicity. Despite mild clinical presentations, updated vaccination and preventive hygiene remain essential to control transmission and protect vulnerable populations. Don’t panic—just practice the basics: mask in crowds, wash hands, keep distance, and update your vaccine.